The European Menopause Survey 2005: Women's perceptions on the menopause and postmenopausal hormone therapy

Abstract

This European survey reveals that the majority of women experience climacteric symptoms but that their decision whether or not to use HT is highly dependent on their concern about breast cancer risk. An increase in knowledge of the benefits and risks of HT is required for women to make appropriate decisions about hormone use.